Development of a prokaryotic model for studying anthracycline-membrane interactions.
Burrow
S M
SM
Department of Applied Biology, University of Central Lancashire.
Rolph
C E
CE
Waring
J J
JJ
Phoenix
D A
DA
D004317:Doxorubicin / Q000494:pharmacology*; D018432:Drug Resistance, Multiple; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism*; D005798:Genes, Bacterial; D007544:Isopropyl Thiogalactoside / Q000494:pharmacology; D008954:Models, Biological; D011401:Promoter Regions, Genetic; D017855:Transferases (Other Substituted Phosphate Groups) / Q000096:biosynthesis
D005227:Fatty Acids; D007544:Isopropyl Thiogalactoside; D004317:Doxorubicin; D017855:Transferases (Other Substituted Phosphate Groups); C020676:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase